KLOW
KLOW peptide blend (GHK-Cu, BPC-157, TB-500 and KPV)
What is KLOW?
KLOW: Vendor/community blend of GHK-Cu + KPV + BPC-157 + TB-500 (component ratios vary by seller) - i.e., GLOW plus KPV (anti-inflammatory alpha-MSH fragment) - composition verified. The sources cited here most often discuss it for: Skin and tissue repair, untested blend; Gut inflammation, animal; Fewer copper skin reactions, anecdotal. Evidence label: Unstudied.
- Type
- Blend
- Family
- Skin, Hair & Tan
- Evidence label
- Unstudied (1 of 5)
- Regulatory status
- As of the July 2026 advisory vote, an FDA panel narrowly recommended BPC-157, KPV and TB-500 for the 503A compounding list against FDA staff advice, but none had been added to the list and none is an FDA-approved drug.
- Goals discussed
- Skin & Glow, Healing & Recovery, Gut & Digestion
- Also called
- KLOW blend, GLOW + KPV, KLOW peptide blend, KLOW Peptide Stack, GHK-Cu / BPC-157 / TB-500 / KPV
- Last reviewed
- 2026-10-11
- Vendor/community blend of GHK-Cu + KPV + BPC-157 + TB-500 (component ratios vary by seller) - i.e., GLOW plus KPV (anti-inflammatory alpha-MSH fragment) - composition verified; not FDA-approved and never studied as a combination.12
Not a single peptide: a supplier-defined mix of four peptides, essentially the GLOW blend plus KPV. Ratios are a market convention and vary between suppliers.
Regulatory status As of the July 2026 advisory vote, an FDA panel narrowly recommended BPC-157, KPV and TB-500 for the 503A compounding list against FDA staff advice, but none had been added to the list and none is an FDA-approved drug. 3
Nanomolar concentrations of KPV inhibit the activation of NF-kappaB and MAP kinase inflammatory signaling pathways, and reduce pro-inflammatory cytokine secretion.
Cell and mouse colitis study of KPV alone, the ingredient that distinguishes KLOW from GLOW; the four-peptide blend itself has not been studied.
What is KLOW researched for?
The three outcomes most discussed for KLOW in the sources below, as those sources report them. humanpeptides.fyi makes no claims of its own: a listed benefit can be unproven or can have failed in trials, and the label on each line says which.
Fewer copper skin reactions, anecdotal
- KPV used by some to reduce GHK-Cu injection-site reactionsanecdotal8
What do researchers and users say about KLOW?
A search of the published literature returns no trial, paper, or patent covering these four compounds together at this ratio.
Evidence review of the KLOW blend on a site that also points readers toward research-peptide suppliers.
My back is clearing up insanely fast. Old scars disappearing completely. Still getting new breakouts but less bad and healing faster.
Self-reported skin changes about a month in, from a commenter also on testosterone therapy; uncontrolled anecdote.
What side effects of KLOW are reported?
- No human or animal study of the 4-peptide blend, interactions or stability; inherits component risksFDA immunogenicity concerns, no human safety data for TB-50041213
- Injection-site redness, itching or bruising, headache, fatigue and temporary changes in bowel habits are the most commonly reported reactions.anecdotal (community guide)14
- Occasional lightheadedness and temporary skin sensitivity are also reported by users.anecdotal (community guide)14
- Users in one thread reported dry mouth shortly after injecting and, in one case, progressive swelling of the legs, ankles, feet and hands within hours.anecdotal11
- Pre-mixed blends cannot be tested for each ingredient's purity separately, and ingredient ratios differ between suppliers.product quality concern10
What do peptide guides say about KLOW?
- Plastic Surgery Key By weight, the common KLOW formulation is about 62.5% GHK-Cu, so it is mostly copper peptide with three smaller additions; the copper is what turns the solution blue. 10
- Seek Peptides Seek Peptides says each KLOW ingredient has its own research record, but the four-peptide combination has been studied far less, so long-term data on the mix is limited. 14
- Seek Peptides Seek Peptides frames KPV as the piece that separates KLOW from GLOW, adding an anti-inflammatory component aimed at gut and joint inflammation on top of the repair-focused trio. 14
- Dr. Axe Dr. Axe classifies KPV, the ingredient that turns GLOW into KLOW, as research-only with evidence limited to cell and mouse studies, and notes FDA has flagged unresolved safety concerns. 15
- AJMC AJMC reports FDA scientists judged the available component studies, including the few small BPC-157 trials, too short and underpowered to establish safety or effectiveness. 3
What does the research say, system by system?
Hormones & physiology1
Cells & mitochondria1
- See GHK-Cu entryin vitro17
How strong is the evidence for KLOW?
No studies of the blend; components mostly animal + anecdotal (GHK-Cu topical has small human data)
No direct studies of this product or blend. Anecdote and component data only. How tiers work
Questions about KLOW
What is KLOW?
Vendor/community blend of GHK-Cu + KPV + BPC-157 + TB-500 (component ratios vary by seller) - i.e., GLOW plus KPV (anti-inflammatory alpha-MSH fragment) - composition verified. Not a single peptide: a supplier-defined mix of four peptides, essentially the GLOW blend plus KPV. Ratios are a market convention and vary between suppliers.
Is KLOW FDA-approved?
As of the July 2026 advisory vote, an FDA panel narrowly recommended BPC-157, KPV and TB-500 for the 503A compounding list against FDA staff advice, but none had been added to the list and none is an FDA-approved drug.
What is KLOW researched for?
The sources cited on this page most often discuss three outcomes: Skin and tissue repair, untested blend; Gut inflammation, animal; Fewer copper skin reactions, anecdotal. Each line above shows what the source reports and how strong that evidence is.
What side effects of KLOW are reported?
Reported in the cited sources: No human or animal study of the 4-peptide blend, interactions or stability; inherits component risks; Injection-site redness, itching or bruising, headache, fatigue and temporary changes in bowel habits are the most commonly reported reactions; Occasional lightheadedness and temporary skin sensitivity are also reported by users. The list is not complete, and few listed risks does not mean a compound is safe.
How strong is the evidence for KLOW?
Evidence label: Unstudied. No studies of the blend; components mostly animal + anecdotal (GHK-Cu topical has small human data).
What else is KLOW called?
Names used for it include KLOW blend, GLOW + KPV, KLOW peptide blend, KLOW Peptide Stack, GHK-Cu / BPC-157 / TB-500 / KPV.
Does humanpeptides.fyi recommend KLOW?
No. humanpeptides.fyi makes no claims and no recommendations of its own. It summarizes and links to what others have published and posted. Nothing here is medical advice; talk to a licensed clinician.